Hutch News

Hutch News

Stories tagged 'precision medicine'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 7, 2017

Fred Hutch Pancreatic cancer researcher Dr. Sunil Hingorani has won a three-year, $1.8 million grant from the federal Cancer Moonshot program, the signature initiative of former Vice President Joseph Biden. Hingorani is one of six collaborators nationwide who received funding this fall for a new research consortium focused on the biological context of pancreatic tumors — such as nearby immune cells or blood vessels — which can have a major impact on a tumor’s vulnerability to treatment.

View story >


Q & A with Dr. Peggy Porter: Targeted breast cancer treatments require diverse research data

Breast cancer researcher discusses need to extend research and results to minority women

Oct. 26, 2017 | By Sabrina Richards and Diane Mapes / Fred Hutch News Service

Personalized breast cancer treatments must come to everyone -- and that requires study data from diverse populations, says breast cancer researcher Dr. Peggy Porter.

View story >


The path to precision screening for cancer

For now, early detection of breast and prostate cancer means mammograms and PSAs, but a more tailored approach is on the horizon

Sept. 29, 2017 | By Diane Mapes / Fred Hutch News Service

For now, screening for breast and prostate cancer involves mammograms, MRIs and PSAs, the best evidence-based tools available at this moment in time. But it won’t be this way forever. Fred Hutch researchers weigh in on where we are on the path to precision prevention.

View story >


Unique set of tissue samples ‘ready to teach’ lessons about pediatric leukemia

Hutch-based repository leads to lifesaving treatments for young cancer patient

Aug. 29, 2017 | By Sabrina Richards / Fred Hutch News Service

A unique, Hutch-based repository of tissue samples ‘ready to teach’ lifesaving lessons about childhood leukemia.

View story >


Bringing a leukemia treatment back to life with precision medicine

New research writes latest chapter in one drug's story

June 27, 2017 | by Susan Keown / Fred Hutch News Service

The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.

View story >


Aspirin and its cousins linked to longer survival after colorectal cancer

Large study of preventive drugs for colorectal cancer survivors finds link to decreased mortality — but only for those with certain tumor genetics

June 15, 2017 | By Rachel Tompa / Fred Hutch News Service

Aspirin and other NSAIDs are linked to decreased mortality in colorectal cancer survivors, a new study finds -- but just for those with the most common tumor subtype.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.